1269232-94-1 Usage
Uses
Used in Pharmaceutical Industry:
CarbaMic acid, N-(3-broMo-5-chloro-2-fluorophenyl)-, 1,1-diMethylethyl ester is used as a synthetic intermediate for the development of pharmaceuticals. Its unique structure and reactivity enable the creation of a diverse range of medicinal compounds, potentially leading to new treatments and therapies.
Used in Agrochemical Industry:
In the agrochemical sector, CarbaMic acid, N-(3-broMo-5-chloro-2-fluorophenyl)-, 1,1-diMethylethyl ester is utilized as a precursor in the production of insecticides, fungicides, and herbicides. Its ability to form stable and effective compounds makes it a valuable component in the development of crop protection products.
Safety Considerations:
Given its potential toxicity and reactivity, CarbaMic acid, N-(3-broMo-5-chloro-2-fluorophenyl)-, 1,1-diMethylethyl ester must be handled and stored with extreme care. Proper safety measures should be implemented to prevent accidents and minimize the risk of environmental contamination.
Check Digit Verification of cas no
The CAS Registry Mumber 1269232-94-1 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,6,9,2,3 and 2 respectively; the second part has 2 digits, 9 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 1269232-94:
(9*1)+(8*2)+(7*6)+(6*9)+(5*2)+(4*3)+(3*2)+(2*9)+(1*4)=171
171 % 10 = 1
So 1269232-94-1 is a valid CAS Registry Number.
1269232-94-1Relevant academic research and scientific papers
Compounds and Compositions as Protein Kinase Inhibitors
-
, (2011/04/14)
The present invention provides compounds of Formula I or II: wherein R1, R1b, R2, R3, R4, R5, R6 and R7 are defined herein. The compounds of Formula (I) or (II) and pharmaceutical compositions thereof are useful for the treatment of B-Raf-associated diseases.
COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS
-
, (2011/04/14)
The invention provides a novel class of compounds of formula 1, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated kinase activity, particularly diseases or disorders that involve abnormal activation of B-Raf.
